VERTEX PHARMACEUTICALS (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

08/02/2018

VAT status

Active

Bankruptcy proceedings

No proceedings

VERTEX PHARMACEUTICALS (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

High

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Incorporation date

08/12/2017

Share capital

5,000.00 PLN

Primary activity

Manufacture of pharmaceutical preparations (21.20.Z - PKD 2007)

Representatives

Representatives rights

KAŻDY CZŁONEK ZARZĄDU UPRAWNIONY JEST DO REPREZENTOWANIA SPÓŁKI SAMODZIELNIE

Representatives

Member of the management boardUlrich Stefan Lentzer

Member of the management boardPrasanna Thombre

Member of the management boardOmar White

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
Ulrich Stefan Lentzer	Member of the management board
Prasanna Thombre	Member of the management board
Omar White	Member of the management board
Trent Townsend	Member of the management board
Marek Michał Macyszyn	Procurator

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

1,571,433

Net Profit (zł)

1,571,433

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
16,682,465
1,155,565
740,021
0.22
2.95
4.44
1,909,196
1,884,188
0
24,377

2023
19,173,263
1,325,795
912,684
0.24
2.11
4.76
2,821,880
4,172,308
0
86,376

2024
22,036,350
2,132,317
1,571,433
0.30
4.40
7.13
4,393,313
1,917,519
0
-

2024
22,036,350
2,132,317
1,571,433
0.30
4.40
7.13
4,393,313
1,917,519
0
-

Turnover (zł)

2024

Turnover (zł)

22,036,350 zł15 % *

Profit before tax (zł)

2,132,317 zł61 % *

Net Profit (zł)

1,571,433 zł72 % *

Working capital requirement (%)

0.30 25.00 % *

Liquidity ratio

4.40 108.53 % *

Net profitability (%)

7.13 %49.79 % *

Equity (zł)

4,393,313 zł56 % *

Current liabilities (zł)

1,917,519 zł-54 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Order report

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

VERTEX PHARMACEUTICALS (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
10/06/2025	OD 01.01.2024 DO 31.12.2024
04/06/2024	OD 01.01.2023 DO 31.12.2023
09/06/2023	OD 01.01.2022 DO 31.12.2022
16/12/2022	OD 01.01.2021 DO 31.12.2021
04/10/2021	OD 01.01.2020 DO 31.12.2020